• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Pluristem Therapeutics, Inc. (PSTI)

    -NasdaqCM
    2.46 Down 0.05(1.99%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.51
    Open:2.49
    Bid:N/A
    Ask:2.92 x 5000
    1y Target Est:5.50
    Beta:-1.34
    Next Earnings Date:N/A
    Day's Range:2.45 - 2.52
    52wk Range:2.32 - 3.78
    Volume:171,868
    Avg Vol (3m):161,090
    Market Cap:193.12M
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PSTI

    Comparison

    Symbol% ChgMkt Cap
    PSTIDown 1.99%193.12M
    ASTM 0.00%N/A
    ACTC 0.00%N/A
    OSIRDown 1.48%662.70M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):471.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.38
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related tech... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback